D-Mannose ameliorates DNCB-induced atopic dermatitis in mice and TNF-α-induced inflammation in human keratinocytes via mTOR/NF-κB pathway
Authors:
- 28 October 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt A) , 109378
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Periostin promotes chronic allergic inflammation in response to Th2 cytokinesJournal of Clinical Investigation, 2012
- Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in miceNature Medicine, 2011
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulationImmunological Reviews, 2011
- Atopic DermatitisAnnals of Dermatology, 2010
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- Epidermal Barrier Dysfunction in Atopic DermatitisJournal of Investigative Dermatology, 2009
- Atopic Dermatitis: A Disease Caused by Innate Immune Defects?Journal of Investigative Dermatology, 2009
- New regulators of NF-κB in inflammationNature Reviews Immunology, 2008
- Triggers of IgE class switching and allergy developmentAnnals of Medicine, 2007
- Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.Journal of Clinical Investigation, 1998